QDAZTI
Live / Applied — Non-final action mailed (as of 05 Feb 2026)
What this means for you
Not registered yet, but its 28 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99465749
- Mark type
- Stylized text
- Filed
- 28 Oct 2025
- Attorney of record
- Heather A. McDonald
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, hormonal disorders, skin disorders, arthritis, cancer, cachexia, hypertension, migraine, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Antifungal preparations; Smoking cessation preparations; Vaccines for human use
Owner
- Pfizer Inc., New York, NY, US
Prosecution history
- 05 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 05 Feb 2026 — NON-FINAL ACTION E-MAILED
- 05 Feb 2026 — NON-FINAL ACTION WRITTEN
- 05 Feb 2026 — ASSIGNED TO EXAMINER
- 28 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 28 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Oct 2025 — NEW APPLICATION ENTERED